This one-hour SERC webinar will bring together pharma industry senior supply chain executives to discuss a topic of utmost personal importance to many Americans: Why have we been experiencing ongoing shortages of critical drugs used in the treatment of life-threatening conditions such as cancers and cardiac ailments; and shortages of even routine medicines prescribed for chronic conditions such as hypertension?
Currently, the U.S. has serious shortages of over 300 critical drugs- from chemotherapeutics to antibiotics. These shortages have once again highlighted the importance of robust supply chains in the pharmaceutical industry. In this webinar, our expert industry panel discusses what's behind these shortages; the impacts of financial, pandemic, climate and regulatory risks; and the key actions needed to ensure a reliable & continuous supply of safe and effective drug products to consumers.
Speakers
- Dov Gardin, Chief Risk Officer, Catalent Pharma Solutions
- Stuart Glickman, V.P. of Supply Chain at Emergent BioSolutions
- Kerry Ingalls, Senior Military and Biotech Executive
Moderator
- Sandor Boyson, Emeritus Research Professor, Smith School
Date
Location
Contact